Roche Diagnostics Deutschland GmbH

And the winner is …. cancer research

The three winners of the first Roche Pharma Research & Development (pRED) Oncology Awards in the field of ‘Novel Highly tumour-selective Membrane Targets for Antibody-based Cancer Therapy’ have been selected. Krishna Chaitanya of the Oncological Institute at the University Hospital Zurich r ... more

New Roche Award for antibody-based cancer therapy research

In a newly created award, pRED`s Discovery Oncology unit of Roche (RHHBY) in Penzberg, Germany invites European researchers to submit abstracts which describe their scientific work in the field of tumor-selective membrane targets for antibody-based cancer therapy. The award aims to honor an ... more

SynenTec To Take Over Roche Cellavista System

Roche and SynenTec announced that Roche will transfer its Cellavista business to SynenTec, the German company which is the original inventor of the Cellavista System. This agreement was made as a result of the Roche Applied Science decision to focus its business, and guarantees future optim ... more

Continuous non-invasive real-time cell monitoring in 384-well plates

Roche’s xCELLigence System RTCA HT Instrument performs real-time impedance-based label-free measurement of cell behavior for high throughput applications. It´s technology is compatible with workflows carrying out automated screening using the 384-wel more

Non-Invasive Real-Time Cell Analytics for Drug Discovery

Roche’s xCELLigence Cardio Instrument is a medium-throughput cell analyzer using impedance recording to monitor cardiac beating and cellular events in real time. The instrument features high resolution detection rate and frequency measurement technol more

RealTime ready RT-qPCR Assay Development and Qualification

On the RealTime ready Configurator, we offer function tested human, mouse, and rat qPCR assays for gene expression quantification based on the unique Universal ProbeLibrary technology (UPL). The Universal ProbeLibrary is a set of short hydrolysis pro more